11,802
Total Claims
$758K
Drug Cost
763
Beneficiaries
$993
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
-95%
Opioid rate vs peers
0.1% vs 2.2% avg
-30%
Cost per patient vs peers
$993 vs $1,411 avg
-12%
Brand preference vs peers
9.4% vs 10.6% avg
Opioid Prescribing
0.1%
Opioid Rate
14
Opioid Claims
$53
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
91% generic
Brand: 1,098 claims · $561K
Generic: 10,635 claims · $194K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 80 | $100K |
| Dulaglutide | 66 | $83K |
| Empagliflozin | 44 | $43K |
| Dapagliflozin Propanediol | 35 | $32K |
| Fluticasone/Umeclidin/Vilanter | 29 | $27K |
| Semaglutide | 25 | $26K |
| Mirabegron | 21 | $26K |
| Linaclotide | 25 | $23K |
| Sitagliptin Phosphate | 14 | $15K |
| Rosuvastatin Calcium | 617 | $11K |
| Exenatide | 12 | $11K |
| Sitagliptin Phos/Metformin Hcl | 11 | $9,886 |
| Levothyroxine Sodium | 83 | $9,695 |
| Pregabalin | 94 | $8,841 |
| Evolocumab | 14 | $8,161 |
Prescribing Profile
Patient Profile
77
Avg Age
78%
Female
1.03
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data